Delivery Order SPE2DR25D3019-SPE2DR26FK4EE
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for M-M-R II vaccine vials valued at $15,511.96 with a firm fixed price contract type. The order is scheduled for completion by December 11, 2025, and will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order contract valued at $18,016.80 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on August 5, 2025, with an ultimate completion date of August 6, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for M-M-R II vaccine vials, with a ceiling value of $1,990.36 and an ultimate completion date of December 15, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with a ceiling value of $4,364.42 and an ultimate completion date of November 4, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award based on open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order under its larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,462.82 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on July 18, 2025, with an ultimate completion date of July 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,028.92 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on December 19, 2025, with completion expected by December 22, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999.99 million through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for M-M-R II vaccine vials with a ceiling value of $1,139.62. This competitively awarded, non-set-aside contract utilizes firm fixed price pricing and requires completion by November 28, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for M-M-R II vaccine vials with a ceiling value of $2,769.45. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The vaccine vials will be delivered to the contractor's corporate office location in...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for M-M-R II vaccine vials valued at $3,593.98 with a firm fixed price structure. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order is set to conclude by August 8,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,371.44 for M-M-R II vaccine vials, with an ultimate completion date of May 13, 2025. This firm fixed-price contract, awarded on May 12, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award is non-competitive and will be performed at...
- SPE2DR25D3019Indefinite Delivery Contract
- SPE2DR25D3019-SPE2DR26FK4EEDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on December 19, 2025, with a contract ceiling value of $3,034.01 and an ultimate completion date of December 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The award is executed as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is a critical vendor for federal medical procurement, particularly for Defense Health Agency and military healthcare systems. The M-M-R II vaccine delivery supports DLA's mission to supply pharmaceutical products and medical supplies to military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive capability in fulfilling diverse medical supply requirements across multiple therapeutic domains, ranging from specialty medications to vaccines and medical devices, with consistent delivery through firm fixed-price arrangements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 12/18/25 |